Results 291 to 300 of about 295,251 (340)
Some of the next articles are maybe not open access.
Pregnancy in End Stage Renal Disease
Seminars in Dialysis, 2011AbstractThe ovulatory menstrual cycle is known to be affected on multiple levels in women with advanced renal disease. Menstrual irregularities, sexual dysfunction, and infertility worsen in parallel with the renal disease. Pregnancy in women with ESRD on dialysis is therefore uncommon.
Andreas Pierratos +4 more
openaire +3 more sources
BMJ clinical evidence, 2006
End stage renal disease (ESRD) affects over 1500 people per million population in countries with a high prevalence, such as the USA and Japan. Approximately two thirds of people with ESRD receive haemodialysis, a quarter have kidney transplants, and a tenth receive peritoneal dialysis.We conducted a systematic review and aimed to answer the following ...
Yoshio, Hall, Glenn, Chertow
openaire +3 more sources
End stage renal disease (ESRD) affects over 1500 people per million population in countries with a high prevalence, such as the USA and Japan. Approximately two thirds of people with ESRD receive haemodialysis, a quarter have kidney transplants, and a tenth receive peritoneal dialysis.We conducted a systematic review and aimed to answer the following ...
Yoshio, Hall, Glenn, Chertow
openaire +3 more sources
Pregnancy and End-Stage Renal Disease
Blood Purification, 2018Pregnancy is uncommon in women with end-stage renal disease (ESRD). Fertility rates are low in women on dialysis, and physicians still frequently counsel women with ESRD against pregnancy. Advancements in the delivery of dialysis and obstetric care have led to improved live birth rates in women on dialysis, so pregnancy for young women with ESRD is now
Molly Nadel +2 more
openaire +3 more sources
BMJ clinical evidence, 2011
End-stage renal disease (ESRD) affects more than 1500 people per million population in countries with a high prevalence, such as Japan, Taiwan, and the US. Approximately two-thirds of people with ESRD receive haemodialysis, one quarter have kidney transplants, and one tenth receive peritoneal dialysis.We conducted a systematic review and aimed to ...
Maaz, Abbasi +2 more
openaire +2 more sources
End-stage renal disease (ESRD) affects more than 1500 people per million population in countries with a high prevalence, such as Japan, Taiwan, and the US. Approximately two-thirds of people with ESRD receive haemodialysis, one quarter have kidney transplants, and one tenth receive peritoneal dialysis.We conducted a systematic review and aimed to ...
Maaz, Abbasi +2 more
openaire +2 more sources
Hyperphosphatemia in end-stage renal disease
Advances in Renal Replacement Therapy, 2002Hyperphosphatemia occurs universally in end-stage renal disease (ESRD) unless efforts are made to prevent positive phosphate balance. Positive phosphate balance results from the loss of renal elimination of phosphate and continued obligatory intestinal absorption of dietary phosphate.
L. Darryl Quarles, Olafur S. Indridason
openaire +3 more sources
Race and End-Stage Renal Disease
New England Journal of Medicine, 1982Experienced nephrologists have long suspected that end-stage renal disease (ESRD) develops more frequently in blacks than in whites in this country, but it was not until 1977 that this suspicion was given epidemiologic support.1 Studying the rate at which new patients with ESRD entered chronic dialysis or renal transplantation programs in a seven ...
openaire +2 more sources
Hyperthyroidism in End-Stage Renal Disease
American Journal of Nephrology, 1985We report the 2nd patient to have hyperthyroidism while on maintenance hemodialysis. This case is instructive because the diagnosis of hyperthyroidism in uremic patients is difficult due to similar signs and symptoms. This case report describes, for the first time, the unique interaction between hemodialysis and thyrotoxic heart disease.
Ronald W. Hamner, Richard J. Foley
openaire +2 more sources
Survival with End-Stage Renal Disease
Annals of Internal Medicine, 1982Excerpt To the editor: Hutchinson and associates (1) make a substantial contribution to the type of analysis needed to understand the natural history of end-stage renal disease.
William P. Argy +3 more
openaire +3 more sources
Pharmacotherapy of end-stage renal disease
Expert Opinion on Pharmacotherapy, 2010The incidence and prevalence of end-stage renal disease (ESRD) requiring renal replacement therapy (RRT) continues to grow worldwide. ESRD causes significant morbidity and mortality and has enormous financial and personal costs.Major electronic databases (including the Cochrane Library, MEDLINE and EMBASE) were searched from 1989 to September 2009 to ...
Stephan R. Lederer +2 more
openaire +3 more sources
2008
There are now approximately one million people on renal replacement therapy worldwide. In the current era of chronic noncommunicable disease, this number is set to double within the next decade. Patients with end-stage renal disease (ESRD) carry a significantly higher cardiovascular morbidity and mortality compared with the general population.
openaire +2 more sources
There are now approximately one million people on renal replacement therapy worldwide. In the current era of chronic noncommunicable disease, this number is set to double within the next decade. Patients with end-stage renal disease (ESRD) carry a significantly higher cardiovascular morbidity and mortality compared with the general population.
openaire +2 more sources